Related Experiment Video
Updated: Feb 9, 2026

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus
Published on: May 13, 2021
Stability and anti-tumor effect of oncolytic herpes simplex virus type 2
Yang Wang1, Jing Jin1, Zhen Wu1
1National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei Provincial Cooperative Innovation Center of Industrial Fermentation, Hubei Key Laboratory of Industrial Microbiology, Hubei University of Technology, Wuhan, 430068, Hubei, China.
Abstract:
Oncolytic virotherapy is a new therapeutic strategy based on the inherent cytotoxicity of viruses and their ability to replicate and spread in tumors in a selective manner. We constructed a new type of oncolytic herpes simplex virus type 2 (oHSV-2, named OH2) to treat human cancers, but a systematic evaluation of the stability and oncolytic ability of this virus is lacking. In this study, we evaluated its physical stability, gene modification stability and biological characteristics stability, including its anti-tumor activity in an animal model. The physical characteristics as well as genetic deletions and insertions in OH2 were stable, and the anti-tumor activity remained stable even after passage of the virus for more than 20 generations. In conclusion, OH2 is a virus that has stable structural and biological traits. Furthermore, OH2 is a potent oncolytic agent against tumor cells.
Insights
A novel oncolytic herpes simplex virus type 2 (OH2) shows stable physical, genetic, and biological traits. This potent oncolytic virus demonstrates consistent anti-tumor activity, making it a promising candidate for cancer therapy.
Area of Science:
- Oncolytic Virotherapy
- Cancer Research
- Virology
Background:
- Oncolytic virotherapy utilizes viruses for selective tumor cell killing and replication.
- Herpes simplex virus type 2 (HSV-2) is being engineered for cancer treatment.
- A comprehensive stability and efficacy assessment of engineered HSV-2 is needed.
Purpose of the Study:
- To construct and systematically evaluate a novel oncolytic HSV-2 (OH2) for human cancer treatment.
- To assess the physical, gene modification, and biological stability of OH2.
- To determine the anti-tumor efficacy of OH2 in an animal model.
Main Methods:
- Construction of OH2, an engineered oncolytic HSV-2.
- Evaluation of physical characteristics and genetic integrity (deletions/insertions) of OH2.
- Assessment of biological stability and anti-tumor activity through multiple viral passages and in vivo studies.
Main Results:
- OH2 demonstrated stable physical characteristics and consistent genetic modifications.
- The virus maintained its biological traits and anti-tumor activity over 20 generations.
- OH2 exhibited potent oncolytic effects against tumor cells in preclinical models.
Conclusions:
- OH2 possesses stable structural and biological properties.
- The engineered virus is a potent oncolytic agent with sustained anti-tumor efficacy.
- OH2 represents a promising candidate for oncolytic virotherapy in cancer treatment.
Related Concept Videos
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Diabetes Mellitus: Type 2 and Gestational
Nuclear Stability
To hold positively charged protons together...
What are Viruses?
RNA Stability
Stability
The stability of an LTI system is determined by the roots of its characteristic equation, known as poles. A system is stable if it produces a bounded...

